We are live on
!
Find out more
SFM
Sphera Funds Management Portfolio holdings
AUM
$630M
1-Year Est. Return
108.65%
This Fund
S&P 500
This Quarter
Est. Return
+2.81%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$628M
AUM Growth
-$105M
(-14%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-21%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
141
New
23
Increased
28
Reduced
42
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$23.5M |
| 2 |
NVMI
Nova
NVMI
|
+$11.1M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$7.99M |
| 4 |
Viking Therapeutics
VKTX
|
+$7.81M |
| 5 |
Check Point Software Technologies
CHKP
|
+$7.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$28.3M |
| 2 |
Cytokinetics
CYTK
|
+$8.91M |
| 3 |
Salesforce
CRM
|
+$8.64M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$7.08M |
| 5 |
ASML
ASML
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70% |
| 2 | Technology | 19.18% |
| 3 | Consumer Discretionary | 3.53% |
| 4 | Communication Services | 2.96% |
| 5 | Utilities | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Insmed
INSM
$21.4B
| – | – |
-16,589
| Closed | -$1.11M |
|
127
Disc Medicine
IRON
$2.96B
| – | – |
-58,044
| Closed | -$2.62M |
|
128
L3Harris
LHX
$51.6B
| – | – |
-10,000
| Closed | -$2.25M |
|
129
Lam Research
LRCX
$367B
| – | – |
-37,000
| Closed | -$3.94M |
|
130
Micron Technology
MU
$930B
| – | – |
-37,000
| Closed | -$4.87M |
|
131
Palo Alto Networks
PANW
$270B
| – | – |
-36,000
| Closed | -$6.1M |
|
132
CALL
Invesco QQQ Trust
QQQ
$453B
| – | – |
-22,900
| Closed | -$11M |
|
133
Cartesian Therapeutics
RNAC
$229M
| – | – |
-25,070
| Closed | -$677K |
|
134
PUT
VanEck Semiconductor ETF
SMH
$65.2B
| – | – |
-149,800
| Closed | -$39.1M |
|
|
SWTX
135
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-70,269
| Closed | -$2.65M |
|
136
Taboola.com
TBLA
$1.37B
| – | – |
-667,384
| Closed | -$2.3M |
|
|
137
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-3,268,900
| Closed | -$53.1M |
|
138
TSMC
TSM
$2.1T
| – | – |
-5,650
| Closed | -$982K |
|
139
Upwork
UPWK
$1.13B
| – | – |
-117,000
| Closed | -$1.26M |
|
140
Varonis Systems
VRNS
$4.59B
| – | – |
-16,000
| Closed | -$768K |
|
Similar funds
VIM
KCMH
FCFC
BI
PWW
TTSTC
SWP
EIM
Sphera Funds Management's Q3 2024 Portfolio in Review
As of Q3 2024, Sphera Funds Management held 141 positions worth $628M, down 14% from $733M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Sphera Funds Management withdrew a net $132M in Q3 2024, closing 26 positions and reducing 42 holdings. Its most notable exit was Salesforce, an estimated $8.64M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Sphera Funds Management opened a new position in Nova worth $10.8M.
- Sphera Funds Management's largest Q3 2024 buy was Nova: 51,960 shares worth $10.8M.
- Sphera Funds Management added most to Teva Pharmaceuticals in Q3 2024, an estimated $23.5M increase.
- Sphera Funds Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $28.3M.
- Sphera Funds Management fully exited Salesforce in Q3 2024, selling an estimated $8.64M.
- Sphera Funds Management's ten largest holdings make up 32% of its $628M portfolio in Q3 2024.
- Sphera Funds Management opened 23 new positions and closed 26 in Q3 2024.
- Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $628M.
Based on Sphera Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.